Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Regimens in Second-line Hormone-refractory Metastatic Prostate Cancer
NCT00627354Phase 2Completed
- Sponsor
- UNICANCER Urogenital Tumor Study Group
- Start
- Sep 2006
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone, etoposide, vinorelbine in prostate cancer (PCa), sponsored by UNICANCER Urogenital Tumor Study Group. Started Sep 2006; status: completed.
02
Drugs
mitoxantroneetoposidevinorelbine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00627354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627354.